Skip to main content
Log in

Misuse of CE thresholds in low- and middle-income countries

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Leech AA, et al. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value in Health : 21 Feb 2018. Available from: URL: https://doi.org/10.1016/j.jval.2017.12.016

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Misuse of CE thresholds in low- and middle-income countries. PharmacoEcon Outcomes News 798, 25 (2018). https://doi.org/10.1007/s40274-018-4772-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4772-y

Navigation